Pisit Duke Pitukcheewanont - 01 Jul 2024 Form 4 Insider Report for LUMOS PHARMA, INC.

Signature
/s/ Ryan Trytten, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Jul 2024
Net transactions value
-$620
Form type
4
Filing time
03 Jul 2024, 19:45:41 UTC
Previous filing
04 Jun 2024
Next filing
13 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction (LUMO) Common Stock Tax liability $620 -274 -1.6% $2.26 16,836 01 Jul 2024 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 1,125 previously reported restricted stock units ("RSUs") granted to the Reporting Person.
F2 Includes 2,625 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on June 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
F3 Includes 3,375 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on July 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
F4 Includes 500 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2024.